TGFB1 and hepatocellular carcinoma: EMT can result in aggressive CAFs with an altered cellular and molecular phenotype in HCC cells; expression of mesenchymal markers and fibroblast-specific proteins is increased with concomitant activation of specific pathways, such as TGF-β, and results in enhanced metastasis (21).